Author: IQ TIMES MEDIA
(Reuters) -The U.S. Food and Drug Administration has approved the expanded use of Johnson & Johnson’s drug Caplyta as an add-on treatment for adults with major depressive disorder, the company said on Thursday.J&J gained access to Caplyta with its $14.6 billion acquisition of neurological drugmaker Intra-Cellular Therapies in January. The FDA’s decision marks the first approval for a drug from the Intra-Cellular stable after the deal.Caplyta can now be used as an adjunctive therapy for patients with depression in combination with oral antidepressants.Major depressive disorder, or clinical depression, is one of the most common psychiatric disorders, affecting about 22 million…
Google is adding Gemini to Maps in India, along with road safety alerts and more information about routes. The AI integration, launched in the U.S. on Wednesday, brings hands-free AI assistance to Maps, as well as contextual suggestions while navigating and information about places of interest. Miriam Daniel, vice president and head of Google Maps, said the rollout required significant localization. “When we say localizing for India, it’s not just the language,” she said at a virtual briefing. “It’s also adapting to how Indians use the product, how Indians will talk, how they will ask for questions, how they will…
(Reuters) -Eli Lilly said on Thursday its experimental obesity drug helped patients lose as much as 20.1% of their weight in a mid-stage trial.The first wave of obesity drugs, which dominate the market, has mainly focused on the gut hormone GLP-1, but drugmakers are now looking for medicines that target other hormones or help preserve muscle mass during fat-loss with their next generation of drugs.The experimental once-weekly drug, eloralintide, belongs to the class of drugs that mimic the pancreatic hormone amylin which slows digestion and suppresses hunger.In an early-stage trial the drug helped some patients lose more than 11% of…
(Reuters) -Eli Lilly said on Thursday its experimental obesity drug helped patients lose as much as 20.1% of their weight in a mid-stage trial.The first wave of obesity drugs, which dominate the market, has mainly focused on the gut hormone GLP-1, but drugmakers are now looking for medicines that target other hormones or help preserve muscle mass during fat-loss with their next generation of drugs.The experimental once-weekly drug, eloralintide, belongs to the class of drugs that mimic the pancreatic hormone amylin which slows digestion and suppresses hunger.In an early-stage trial the drug helped some patients lose more than 11% of…
Good morning!🙋🏼♀️ I’m Nicole Fallert. I need a “Bearista” cup.Quick look at Thursday’s news:Flight cuts coming to major airportsTransportation Secretary Sean Duffy announced in a news conference that there will be a 10% reduction in flights at 40 major airports at the end of the week due to the impacts of the ongoing federal government shutdown.What happened next: The drastic plan for flight reductions sent airlines scrambling to make significant reductions in flights in just 36 hours and passengers flooded airline customer service hotlines with concerns about air travel in the coming days.”Regional flying” may be on the chopping block. United…
Good morning!🙋🏼♀️ I’m Nicole Fallert. I need a “Bearista” cup.Quick look at Thursday’s news:Flight cuts coming to major airportsTransportation Secretary Sean Duffy announced in a news conference that there will be a 10% reduction in flights at 40 major airports at the end of the week due to the impacts of the ongoing federal government shutdown.What happened next: The drastic plan for flight reductions sent airlines scrambling to make significant reductions in flights in just 36 hours and passengers flooded airline customer service hotlines with concerns about air travel in the coming days.”Regional flying” may be on the chopping block. United…
De PERE, Wis. (AP) — Cora Anderson and Madison DeCleene spent their first two years at Division III St. Norbert College believing their academic pursuits would force them to end their athletic careers earlier than they wanted.An NCAA pilot program gave them another chance to keep competing. The program allows D-III athletes to continue playing at schools they no longer attend under certain conditions. Anderson and DeCleene remain on the track and field team for St. Norbert – where they spent their first two years – even though they now attend nearby Bellin College. The two schools are located about…
By Pushkala Aripaka and Maggie Fick(Reuters) -AstraZeneca beat expectations for third quarter earnings on Thursday with strong sales of its blockbuster cancer and cardiovascular drugs, but disappointed some investors by not raising its full-year forecasts.The Anglo-Swedish drugmaker is looking to new launches, including a blood pressure drug, to offset patent expiries for medicines such as diabetes and heart treatment Farxiga as it pursues its goal of annual revenue of $80 billion by 2030.”The strong underlying momentum across our business through the first nine months of the year sets us up well to sustain growth through 2026 and has us on…
By Pushkala Aripaka and Maggie Fick(Reuters) -AstraZeneca beat expectations for third quarter earnings on Thursday with strong sales of its blockbuster cancer and cardiovascular drugs, but disappointed some investors by not raising its full-year forecasts.The Anglo-Swedish drugmaker is looking to new launches, including a blood pressure drug, to offset patent expiries for medicines such as diabetes and heart treatment Farxiga as it pursues its goal of annual revenue of $80 billion by 2030.”The strong underlying momentum across our business through the first nine months of the year sets us up well to sustain growth through 2026 and has us on…
Brat summer is over and done with, but the viral bright green album cover continues to be relevant — just ask Figma CEO Dylan Field.During the “Uncapped with Jack Altman” podcast published on Wednesday, Field said the album is an example of why AI won’t replace human designers anytime soon.”I think we are so far away from AI replacing designers, and if you actually look at the designs generated, I think it’s very easy to tell that,” Field said. “But even if the design generation from an aesthetic standpoint gets better, it’s not considering the entire system.”Field told Altman, the…